Citi raised the firm’s price target on McKesson (MCK) to $670 from $620 and keeps a Buy rating on the shares. The analyst believes the Q2 reports from the healthcare distribution group are set to a “stock pickers earnings season.” The firm likes the setup for Cencora (COR) the best.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK: